Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver
- 1 April 1998
- journal article
- Published by Elsevier in Life Sciences
- Vol. 62 (20) , 1861-1873
- https://doi.org/10.1016/s0024-3205(98)00152-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the ratHepatology, 1997
- G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal ApoptosisJournal of Neuroscience, 1997
- Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5European Journal of Biochemistry, 1997
- Plasmodium falciparum protein kinase 5 and the malarial nuclear division cyclesMolecular and Biochemical Parasitology, 1996
- Urinary and Biliary Metabolites of Genistein in Rats.Biological & Pharmaceutical Bulletin, 1996
- Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275Biochemical and Biophysical Research Communications, 1994
- Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transportEuropean Journal of Pharmacology: Environmental Toxicology and Pharmacology, 1994
- Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells: Correlation with decreased H1 kinase activityBiochemical Pharmacology, 1993
- Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275JNCI Journal of the National Cancer Institute, 1992
- Pharmacological effects of drug conjugates: is morphine 6-glucuronide an exception?Trends in Pharmacological Sciences, 1992